JBM (Healthcare) Limited Profile Avatar - Palmy Investing

JBM (Healthcare) Limited

JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter …
Drug Manufacturers - Specialty & Generic
HK, Kwun Tong [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth n.A. n.A.
Leverage & Liquidity 33% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q2 Δ in %
Current Ratio -2.58 1.66 1.70
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -75.42 -0.07 0.30
Naive Interpretation member
2 Per Share
Metric Q4 Q2 Δ in %
Book Value -1.83 1.08 1.10
Cash -1.93 0.16 0.16
Capex n.A. n.A. -0.01
Free Cash Flow n.A. n.A. 0.05
Revenue -0.21 0.36 0.36
Naive Interpretation member
3 Profitability
Metric Q4 Q2 Δ in %
Gross Margin -0.84 0.52 0.52
Operating Margin 1.75 0.25 0.24
ROA 12.36 0.05 0.04
ROE 12.47 0.07 0.06
ROIC 11.91 0.06 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2161.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2161.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2161.HK is permitted for members.